nodes	percent_of_prediction	percent_of_DWPC	metapath
Tobramycin—Framycetin—CXCR4—sarcoma	0.052	1	CrCbGaD
Tobramycin—Renal impairment—Epirubicin—sarcoma	0.00153	0.00161	CcSEcCtD
Tobramycin—Pain—Thiotepa—sarcoma	0.00152	0.0016	CcSEcCtD
Tobramycin—Back pain—Etoposide—sarcoma	0.00151	0.0016	CcSEcCtD
Tobramycin—Pain—Dactinomycin—sarcoma	0.00151	0.00159	CcSEcCtD
Tobramycin—Thrombocytopenia—Mitoxantrone—sarcoma	0.0015	0.00159	CcSEcCtD
Tobramycin—Anorexia—Vincristine—sarcoma	0.0015	0.00159	CcSEcCtD
Tobramycin—Eye pain—Doxorubicin—sarcoma	0.00149	0.00157	CcSEcCtD
Tobramycin—Skin disorder—Mitoxantrone—sarcoma	0.00149	0.00157	CcSEcCtD
Tobramycin—Lethargy—Epirubicin—sarcoma	0.00149	0.00157	CcSEcCtD
Tobramycin—Feeling abnormal—Thiotepa—sarcoma	0.00147	0.00155	CcSEcCtD
Tobramycin—Anorexia—Mitoxantrone—sarcoma	0.00146	0.00154	CcSEcCtD
Tobramycin—Renal failure acute—Doxorubicin—sarcoma	0.00146	0.00154	CcSEcCtD
Tobramycin—Feeling abnormal—Dactinomycin—sarcoma	0.00145	0.00153	CcSEcCtD
Tobramycin—Gastrointestinal pain—Thiotepa—sarcoma	0.00145	0.00153	CcSEcCtD
Tobramycin—Ill-defined disorder—Etoposide—sarcoma	0.00145	0.00153	CcSEcCtD
Tobramycin—Anaemia—Etoposide—sarcoma	0.00145	0.00153	CcSEcCtD
Tobramycin—Gastrointestinal pain—Dactinomycin—sarcoma	0.00144	0.00152	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Vincristine—sarcoma	0.00144	0.00152	CcSEcCtD
Tobramycin—Dermatitis exfoliative—Doxorubicin—sarcoma	0.00143	0.00151	CcSEcCtD
Tobramycin—Renal impairment—Doxorubicin—sarcoma	0.00142	0.00149	CcSEcCtD
Tobramycin—Paraesthesia—Vincristine—sarcoma	0.00142	0.00149	CcSEcCtD
Tobramycin—Urticaria—Thiotepa—sarcoma	0.00141	0.00149	CcSEcCtD
Tobramycin—Malaise—Etoposide—sarcoma	0.00141	0.00149	CcSEcCtD
Tobramycin—Vertigo—Etoposide—sarcoma	0.00141	0.00148	CcSEcCtD
Tobramycin—Body temperature increased—Thiotepa—sarcoma	0.00141	0.00148	CcSEcCtD
Tobramycin—Abdominal pain—Thiotepa—sarcoma	0.00141	0.00148	CcSEcCtD
Tobramycin—Leukopenia—Etoposide—sarcoma	0.0014	0.00148	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.0014	0.00148	CcSEcCtD
Tobramycin—Body temperature increased—Dactinomycin—sarcoma	0.0014	0.00147	CcSEcCtD
Tobramycin—Abdominal pain—Dactinomycin—sarcoma	0.0014	0.00147	CcSEcCtD
Tobramycin—Paraesthesia—Mitoxantrone—sarcoma	0.00138	0.00145	CcSEcCtD
Tobramycin—Lethargy—Doxorubicin—sarcoma	0.00138	0.00145	CcSEcCtD
Tobramycin—Decreased appetite—Vincristine—sarcoma	0.00137	0.00145	CcSEcCtD
Tobramycin—Dyspnoea—Mitoxantrone—sarcoma	0.00137	0.00144	CcSEcCtD
Tobramycin—Cough—Etoposide—sarcoma	0.00137	0.00144	CcSEcCtD
Tobramycin—Blood creatinine increased—Epirubicin—sarcoma	0.00136	0.00144	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Vincristine—sarcoma	0.00136	0.00144	CcSEcCtD
Tobramycin—Dehydration—Epirubicin—sarcoma	0.00135	0.00143	CcSEcCtD
Tobramycin—Pain—Vincristine—sarcoma	0.00135	0.00142	CcSEcCtD
Tobramycin—Dry skin—Epirubicin—sarcoma	0.00134	0.00141	CcSEcCtD
Tobramycin—Decreased appetite—Mitoxantrone—sarcoma	0.00133	0.00141	CcSEcCtD
Tobramycin—Chest pain—Etoposide—sarcoma	0.00133	0.00141	CcSEcCtD
Tobramycin—Hypokalaemia—Epirubicin—sarcoma	0.00133	0.0014	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00132	0.0014	CcSEcCtD
Tobramycin—Discomfort—Etoposide—sarcoma	0.00132	0.00139	CcSEcCtD
Tobramycin—Pain—Mitoxantrone—sarcoma	0.00131	0.00139	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.00131	0.00138	CcSEcCtD
Tobramycin—Hypersensitivity—Thiotepa—sarcoma	0.00131	0.00138	CcSEcCtD
Tobramycin—Hypersensitivity—Dactinomycin—sarcoma	0.0013	0.00137	CcSEcCtD
Tobramycin—Gastrointestinal pain—Vincristine—sarcoma	0.00129	0.00136	CcSEcCtD
Tobramycin—Confusional state—Etoposide—sarcoma	0.00129	0.00136	CcSEcCtD
Tobramycin—Muscular weakness—Epirubicin—sarcoma	0.00128	0.00136	CcSEcCtD
Tobramycin—Anaphylactic shock—Etoposide—sarcoma	0.00128	0.00135	CcSEcCtD
Tobramycin—Asthenia—Thiotepa—sarcoma	0.00128	0.00135	CcSEcCtD
Tobramycin—Asthenia—Dactinomycin—sarcoma	0.00127	0.00134	CcSEcCtD
Tobramycin—Feeling abnormal—Mitoxantrone—sarcoma	0.00127	0.00133	CcSEcCtD
Tobramycin—Blood creatinine increased—Doxorubicin—sarcoma	0.00126	0.00133	CcSEcCtD
Tobramycin—Asthma—Epirubicin—sarcoma	0.00126	0.00133	CcSEcCtD
Tobramycin—Pruritus—Thiotepa—sarcoma	0.00126	0.00133	CcSEcCtD
Tobramycin—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00126	0.00132	CcSEcCtD
Tobramycin—Dehydration—Doxorubicin—sarcoma	0.00125	0.00132	CcSEcCtD
Tobramycin—Thrombocytopenia—Etoposide—sarcoma	0.00125	0.00132	CcSEcCtD
Tobramycin—Eosinophilia—Epirubicin—sarcoma	0.00125	0.00131	CcSEcCtD
Tobramycin—Body temperature increased—Vincristine—sarcoma	0.00125	0.00131	CcSEcCtD
Tobramycin—Abdominal pain—Vincristine—sarcoma	0.00125	0.00131	CcSEcCtD
Tobramycin—Skin disorder—Etoposide—sarcoma	0.00124	0.00131	CcSEcCtD
Tobramycin—Dry skin—Doxorubicin—sarcoma	0.00124	0.0013	CcSEcCtD
Tobramycin—Hypokalaemia—Doxorubicin—sarcoma	0.00123	0.00129	CcSEcCtD
Tobramycin—Urticaria—Mitoxantrone—sarcoma	0.00122	0.00129	CcSEcCtD
Tobramycin—Anorexia—Etoposide—sarcoma	0.00122	0.00128	CcSEcCtD
Tobramycin—Diarrhoea—Thiotepa—sarcoma	0.00122	0.00128	CcSEcCtD
Tobramycin—Body temperature increased—Mitoxantrone—sarcoma	0.00121	0.00128	CcSEcCtD
Tobramycin—Abdominal pain—Mitoxantrone—sarcoma	0.00121	0.00128	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.00121	0.00128	CcSEcCtD
Tobramycin—Bronchitis—Epirubicin—sarcoma	0.00121	0.00128	CcSEcCtD
Tobramycin—Diarrhoea—Dactinomycin—sarcoma	0.00121	0.00127	CcSEcCtD
Tobramycin—Muscular weakness—Doxorubicin—sarcoma	0.00119	0.00125	CcSEcCtD
Tobramycin—Dizziness—Thiotepa—sarcoma	0.00118	0.00124	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Epirubicin—sarcoma	0.00117	0.00123	CcSEcCtD
Tobramycin—Asthma—Doxorubicin—sarcoma	0.00116	0.00123	CcSEcCtD
Tobramycin—Hypersensitivity—Vincristine—sarcoma	0.00116	0.00123	CcSEcCtD
Tobramycin—Eosinophilia—Doxorubicin—sarcoma	0.00115	0.00122	CcSEcCtD
Tobramycin—Paraesthesia—Etoposide—sarcoma	0.00115	0.00121	CcSEcCtD
Tobramycin—Weight decreased—Epirubicin—sarcoma	0.00114	0.0012	CcSEcCtD
Tobramycin—Dyspnoea—Etoposide—sarcoma	0.00114	0.0012	CcSEcCtD
Tobramycin—Hypersensitivity—Mitoxantrone—sarcoma	0.00113	0.00119	CcSEcCtD
Tobramycin—Asthenia—Vincristine—sarcoma	0.00113	0.00119	CcSEcCtD
Tobramycin—Vomiting—Thiotepa—sarcoma	0.00113	0.00119	CcSEcCtD
Tobramycin—Infestation—Epirubicin—sarcoma	0.00112	0.00118	CcSEcCtD
Tobramycin—Infestation NOS—Epirubicin—sarcoma	0.00112	0.00118	CcSEcCtD
Tobramycin—Vomiting—Dactinomycin—sarcoma	0.00112	0.00118	CcSEcCtD
Tobramycin—Rash—Thiotepa—sarcoma	0.00112	0.00118	CcSEcCtD
Tobramycin—Bronchitis—Doxorubicin—sarcoma	0.00112	0.00118	CcSEcCtD
Tobramycin—Dermatitis—Thiotepa—sarcoma	0.00112	0.00118	CcSEcCtD
Tobramycin—Headache—Thiotepa—sarcoma	0.00111	0.00118	CcSEcCtD
Tobramycin—Rash—Dactinomycin—sarcoma	0.00111	0.00117	CcSEcCtD
Tobramycin—Decreased appetite—Etoposide—sarcoma	0.00111	0.00117	CcSEcCtD
Tobramycin—Renal failure—Epirubicin—sarcoma	0.0011	0.00116	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Etoposide—sarcoma	0.0011	0.00116	CcSEcCtD
Tobramycin—Asthenia—Mitoxantrone—sarcoma	0.0011	0.00116	CcSEcCtD
Tobramycin—Neuropathy peripheral—Epirubicin—sarcoma	0.0011	0.00116	CcSEcCtD
Tobramycin—Stomatitis—Epirubicin—sarcoma	0.00109	0.00115	CcSEcCtD
Tobramycin—Pain—Etoposide—sarcoma	0.00109	0.00115	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Doxorubicin—sarcoma	0.00108	0.00114	CcSEcCtD
Tobramycin—Diarrhoea—Vincristine—sarcoma	0.00108	0.00114	CcSEcCtD
Tobramycin—Epistaxis—Epirubicin—sarcoma	0.00106	0.00112	CcSEcCtD
Tobramycin—Nausea—Thiotepa—sarcoma	0.00106	0.00111	CcSEcCtD
Tobramycin—Weight decreased—Doxorubicin—sarcoma	0.00105	0.00111	CcSEcCtD
Tobramycin—Sinusitis—Epirubicin—sarcoma	0.00105	0.00111	CcSEcCtD
Tobramycin—Feeling abnormal—Etoposide—sarcoma	0.00105	0.00111	CcSEcCtD
Tobramycin—Diarrhoea—Mitoxantrone—sarcoma	0.00105	0.00111	CcSEcCtD
Tobramycin—Nausea—Dactinomycin—sarcoma	0.00105	0.00111	CcSEcCtD
Tobramycin—Agranulocytosis—Epirubicin—sarcoma	0.00105	0.00111	CcSEcCtD
Tobramycin—Gastrointestinal pain—Etoposide—sarcoma	0.00104	0.0011	CcSEcCtD
Tobramycin—Dizziness—Vincristine—sarcoma	0.00104	0.0011	CcSEcCtD
Tobramycin—Infestation—Doxorubicin—sarcoma	0.00104	0.0011	CcSEcCtD
Tobramycin—Infestation NOS—Doxorubicin—sarcoma	0.00104	0.0011	CcSEcCtD
Tobramycin—Renal failure—Doxorubicin—sarcoma	0.00102	0.00108	CcSEcCtD
Tobramycin—Neuropathy peripheral—Doxorubicin—sarcoma	0.00102	0.00107	CcSEcCtD
Tobramycin—Urticaria—Etoposide—sarcoma	0.00101	0.00107	CcSEcCtD
Tobramycin—Stomatitis—Doxorubicin—sarcoma	0.00101	0.00107	CcSEcCtD
Tobramycin—Rhinitis—Epirubicin—sarcoma	0.00101	0.00107	CcSEcCtD
Tobramycin—Abdominal pain—Etoposide—sarcoma	0.00101	0.00107	CcSEcCtD
Tobramycin—Body temperature increased—Etoposide—sarcoma	0.00101	0.00107	CcSEcCtD
Tobramycin—Vomiting—Vincristine—sarcoma	0.001	0.00106	CcSEcCtD
Tobramycin—Pharyngitis—Epirubicin—sarcoma	0.001	0.00106	CcSEcCtD
Tobramycin—Urinary tract disorder—Epirubicin—sarcoma	0.000995	0.00105	CcSEcCtD
Tobramycin—Rash—Vincristine—sarcoma	0.000994	0.00105	CcSEcCtD
Tobramycin—Dermatitis—Vincristine—sarcoma	0.000993	0.00105	CcSEcCtD
Tobramycin—Connective tissue disorder—Epirubicin—sarcoma	0.00099	0.00104	CcSEcCtD
Tobramycin—Urethral disorder—Epirubicin—sarcoma	0.000988	0.00104	CcSEcCtD
Tobramycin—Headache—Vincristine—sarcoma	0.000988	0.00104	CcSEcCtD
Tobramycin—Epistaxis—Doxorubicin—sarcoma	0.00098	0.00103	CcSEcCtD
Tobramycin—Vomiting—Mitoxantrone—sarcoma	0.000976	0.00103	CcSEcCtD
Tobramycin—Sinusitis—Doxorubicin—sarcoma	0.000975	0.00103	CcSEcCtD
Tobramycin—Visual impairment—Epirubicin—sarcoma	0.000971	0.00102	CcSEcCtD
Tobramycin—Agranulocytosis—Doxorubicin—sarcoma	0.000969	0.00102	CcSEcCtD
Tobramycin—Rash—Mitoxantrone—sarcoma	0.000968	0.00102	CcSEcCtD
Tobramycin—Dermatitis—Mitoxantrone—sarcoma	0.000967	0.00102	CcSEcCtD
Tobramycin—Headache—Mitoxantrone—sarcoma	0.000962	0.00101	CcSEcCtD
Tobramycin—Eye disorder—Epirubicin—sarcoma	0.000942	0.000993	CcSEcCtD
Tobramycin—Hypersensitivity—Etoposide—sarcoma	0.000941	0.000993	CcSEcCtD
Tobramycin—Tinnitus—Epirubicin—sarcoma	0.00094	0.000991	CcSEcCtD
Tobramycin—Nausea—Vincristine—sarcoma	0.000937	0.000988	CcSEcCtD
Tobramycin—Rhinitis—Doxorubicin—sarcoma	0.000935	0.000986	CcSEcCtD
Tobramycin—Pharyngitis—Doxorubicin—sarcoma	0.000925	0.000976	CcSEcCtD
Tobramycin—Urinary tract disorder—Doxorubicin—sarcoma	0.000921	0.000971	CcSEcCtD
Tobramycin—Asthenia—Etoposide—sarcoma	0.000916	0.000967	CcSEcCtD
Tobramycin—Connective tissue disorder—Doxorubicin—sarcoma	0.000916	0.000967	CcSEcCtD
Tobramycin—Angiopathy—Epirubicin—sarcoma	0.000914	0.000964	CcSEcCtD
Tobramycin—Urethral disorder—Doxorubicin—sarcoma	0.000914	0.000964	CcSEcCtD
Tobramycin—Nausea—Mitoxantrone—sarcoma	0.000912	0.000962	CcSEcCtD
Tobramycin—Immune system disorder—Epirubicin—sarcoma	0.00091	0.00096	CcSEcCtD
Tobramycin—Mediastinal disorder—Epirubicin—sarcoma	0.000908	0.000958	CcSEcCtD
Tobramycin—Pruritus—Etoposide—sarcoma	0.000904	0.000953	CcSEcCtD
Tobramycin—Visual impairment—Doxorubicin—sarcoma	0.000899	0.000948	CcSEcCtD
Tobramycin—Erythema—Epirubicin—sarcoma	0.000877	0.000925	CcSEcCtD
Tobramycin—Diarrhoea—Etoposide—sarcoma	0.000874	0.000922	CcSEcCtD
Tobramycin—Eye disorder—Doxorubicin—sarcoma	0.000871	0.000919	CcSEcCtD
Tobramycin—Tinnitus—Doxorubicin—sarcoma	0.000869	0.000917	CcSEcCtD
Tobramycin—Dysgeusia—Epirubicin—sarcoma	0.000859	0.000906	CcSEcCtD
Tobramycin—Back pain—Epirubicin—sarcoma	0.000849	0.000895	CcSEcCtD
Tobramycin—Angiopathy—Doxorubicin—sarcoma	0.000846	0.000892	CcSEcCtD
Tobramycin—Dizziness—Etoposide—sarcoma	0.000845	0.000891	CcSEcCtD
Tobramycin—Immune system disorder—Doxorubicin—sarcoma	0.000842	0.000888	CcSEcCtD
Tobramycin—Mediastinal disorder—Doxorubicin—sarcoma	0.00084	0.000886	CcSEcCtD
Tobramycin—Vision blurred—Epirubicin—sarcoma	0.000827	0.000872	CcSEcCtD
Tobramycin—Ill-defined disorder—Epirubicin—sarcoma	0.000814	0.000859	CcSEcCtD
Tobramycin—Vomiting—Etoposide—sarcoma	0.000812	0.000857	CcSEcCtD
Tobramycin—Erythema—Doxorubicin—sarcoma	0.000812	0.000856	CcSEcCtD
Tobramycin—Anaemia—Epirubicin—sarcoma	0.000811	0.000855	CcSEcCtD
Tobramycin—Rash—Etoposide—sarcoma	0.000805	0.00085	CcSEcCtD
Tobramycin—Dermatitis—Etoposide—sarcoma	0.000805	0.000849	CcSEcCtD
Tobramycin—Headache—Etoposide—sarcoma	0.0008	0.000844	CcSEcCtD
Tobramycin—Dysgeusia—Doxorubicin—sarcoma	0.000795	0.000838	CcSEcCtD
Tobramycin—Malaise—Epirubicin—sarcoma	0.000791	0.000835	CcSEcCtD
Tobramycin—Vertigo—Epirubicin—sarcoma	0.000788	0.000831	CcSEcCtD
Tobramycin—Leukopenia—Epirubicin—sarcoma	0.000785	0.000828	CcSEcCtD
Tobramycin—Back pain—Doxorubicin—sarcoma	0.000785	0.000828	CcSEcCtD
Tobramycin—Cough—Epirubicin—sarcoma	0.000766	0.000808	CcSEcCtD
Tobramycin—Vision blurred—Doxorubicin—sarcoma	0.000765	0.000807	CcSEcCtD
Tobramycin—Nausea—Etoposide—sarcoma	0.000759	0.0008	CcSEcCtD
Tobramycin—Ill-defined disorder—Doxorubicin—sarcoma	0.000753	0.000794	CcSEcCtD
Tobramycin—Anaemia—Doxorubicin—sarcoma	0.00075	0.000791	CcSEcCtD
Tobramycin—Myalgia—Epirubicin—sarcoma	0.000747	0.000788	CcSEcCtD
Tobramycin—Chest pain—Epirubicin—sarcoma	0.000747	0.000788	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000742	0.000782	CcSEcCtD
Tobramycin—Discomfort—Epirubicin—sarcoma	0.000738	0.000778	CcSEcCtD
Tobramycin—Malaise—Doxorubicin—sarcoma	0.000732	0.000772	CcSEcCtD
Tobramycin—Vertigo—Doxorubicin—sarcoma	0.000729	0.000769	CcSEcCtD
Tobramycin—Leukopenia—Doxorubicin—sarcoma	0.000727	0.000766	CcSEcCtD
Tobramycin—Confusional state—Epirubicin—sarcoma	0.000722	0.000762	CcSEcCtD
Tobramycin—Anaphylactic shock—Epirubicin—sarcoma	0.000716	0.000755	CcSEcCtD
Tobramycin—Cough—Doxorubicin—sarcoma	0.000708	0.000747	CcSEcCtD
Tobramycin—Nervous system disorder—Epirubicin—sarcoma	0.000702	0.000741	CcSEcCtD
Tobramycin—Thrombocytopenia—Epirubicin—sarcoma	0.000701	0.000739	CcSEcCtD
Tobramycin—Skin disorder—Epirubicin—sarcoma	0.000695	0.000734	CcSEcCtD
Tobramycin—Chest pain—Doxorubicin—sarcoma	0.000691	0.000729	CcSEcCtD
Tobramycin—Myalgia—Doxorubicin—sarcoma	0.000691	0.000729	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000686	0.000724	CcSEcCtD
Tobramycin—Discomfort—Doxorubicin—sarcoma	0.000683	0.00072	CcSEcCtD
Tobramycin—Anorexia—Epirubicin—sarcoma	0.000682	0.00072	CcSEcCtD
Tobramycin—Confusional state—Doxorubicin—sarcoma	0.000668	0.000705	CcSEcCtD
Tobramycin—Anaphylactic shock—Doxorubicin—sarcoma	0.000662	0.000699	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000652	0.000688	CcSEcCtD
Tobramycin—Nervous system disorder—Doxorubicin—sarcoma	0.00065	0.000685	CcSEcCtD
Tobramycin—Thrombocytopenia—Doxorubicin—sarcoma	0.000649	0.000684	CcSEcCtD
Tobramycin—Skin disorder—Doxorubicin—sarcoma	0.000643	0.000679	CcSEcCtD
Tobramycin—Paraesthesia—Epirubicin—sarcoma	0.000643	0.000678	CcSEcCtD
Tobramycin—Dyspnoea—Epirubicin—sarcoma	0.000638	0.000673	CcSEcCtD
Tobramycin—Anorexia—Doxorubicin—sarcoma	0.000631	0.000666	CcSEcCtD
Tobramycin—Decreased appetite—Epirubicin—sarcoma	0.000622	0.000657	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Epirubicin—sarcoma	0.000618	0.000652	CcSEcCtD
Tobramycin—Pain—Epirubicin—sarcoma	0.000612	0.000646	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000604	0.000637	CcSEcCtD
Tobramycin—Paraesthesia—Doxorubicin—sarcoma	0.000595	0.000627	CcSEcCtD
Tobramycin—Dyspnoea—Doxorubicin—sarcoma	0.000591	0.000623	CcSEcCtD
Tobramycin—Feeling abnormal—Epirubicin—sarcoma	0.00059	0.000622	CcSEcCtD
Tobramycin—Gastrointestinal pain—Epirubicin—sarcoma	0.000585	0.000618	CcSEcCtD
Tobramycin—Decreased appetite—Doxorubicin—sarcoma	0.000576	0.000607	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000572	0.000603	CcSEcCtD
Tobramycin—Urticaria—Epirubicin—sarcoma	0.000569	0.0006	CcSEcCtD
Tobramycin—Pain—Doxorubicin—sarcoma	0.000567	0.000598	CcSEcCtD
Tobramycin—Abdominal pain—Epirubicin—sarcoma	0.000566	0.000597	CcSEcCtD
Tobramycin—Body temperature increased—Epirubicin—sarcoma	0.000566	0.000597	CcSEcCtD
Tobramycin—Feeling abnormal—Doxorubicin—sarcoma	0.000546	0.000576	CcSEcCtD
Tobramycin—Gastrointestinal pain—Doxorubicin—sarcoma	0.000542	0.000571	CcSEcCtD
Tobramycin—Hypersensitivity—Epirubicin—sarcoma	0.000528	0.000556	CcSEcCtD
Tobramycin—Urticaria—Doxorubicin—sarcoma	0.000526	0.000555	CcSEcCtD
Tobramycin—Abdominal pain—Doxorubicin—sarcoma	0.000524	0.000552	CcSEcCtD
Tobramycin—Body temperature increased—Doxorubicin—sarcoma	0.000524	0.000552	CcSEcCtD
Tobramycin—Asthenia—Epirubicin—sarcoma	0.000514	0.000542	CcSEcCtD
Tobramycin—Pruritus—Epirubicin—sarcoma	0.000507	0.000534	CcSEcCtD
Tobramycin—Diarrhoea—Epirubicin—sarcoma	0.00049	0.000517	CcSEcCtD
Tobramycin—Hypersensitivity—Doxorubicin—sarcoma	0.000488	0.000515	CcSEcCtD
Tobramycin—Asthenia—Doxorubicin—sarcoma	0.000475	0.000501	CcSEcCtD
Tobramycin—Dizziness—Epirubicin—sarcoma	0.000473	0.000499	CcSEcCtD
Tobramycin—Pruritus—Doxorubicin—sarcoma	0.000469	0.000494	CcSEcCtD
Tobramycin—Vomiting—Epirubicin—sarcoma	0.000455	0.00048	CcSEcCtD
Tobramycin—Diarrhoea—Doxorubicin—sarcoma	0.000453	0.000478	CcSEcCtD
Tobramycin—Rash—Epirubicin—sarcoma	0.000451	0.000476	CcSEcCtD
Tobramycin—Dermatitis—Epirubicin—sarcoma	0.000451	0.000476	CcSEcCtD
Tobramycin—Headache—Epirubicin—sarcoma	0.000449	0.000473	CcSEcCtD
Tobramycin—Dizziness—Doxorubicin—sarcoma	0.000438	0.000462	CcSEcCtD
Tobramycin—Nausea—Epirubicin—sarcoma	0.000425	0.000449	CcSEcCtD
Tobramycin—Vomiting—Doxorubicin—sarcoma	0.000421	0.000444	CcSEcCtD
Tobramycin—Rash—Doxorubicin—sarcoma	0.000418	0.000441	CcSEcCtD
Tobramycin—Dermatitis—Doxorubicin—sarcoma	0.000417	0.00044	CcSEcCtD
Tobramycin—Headache—Doxorubicin—sarcoma	0.000415	0.000438	CcSEcCtD
Tobramycin—Nausea—Doxorubicin—sarcoma	0.000394	0.000415	CcSEcCtD
